cohortGo,feature,e_nr,ne_nr,e_r,ne_r,events,no_events,responders,non_responders,total_patients,direction,fisher_pval,or,ci_low,ci_high,group,ct,no_dcb,dcb,type,p_bh,p_by,q,derived_treatmentName,derived_treatmentMechanism,treatment,mechanism,alpha_gp,highlight,color_gp
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_ANGIOGENESIS_gt75,13,21,0,19,13,40,19,34,53,Non-Response,0.00181237019890678,0,0,0.435638065266545,mechanism,59,37,22,univariate,0.0897887328881563,1,0.0897887328881563,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,,TRUE,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt50,14,20,0,19,14,39,19,34,53,Non-Response,0.000779316045332524,0,0,0.383747990351625,mechanism,59,37,22,univariate,0.0533131887421224,0.65677451777715,0.0533131887421224,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,,TRUE,Anti-PD-1
Bladder Urothelial ## Pembrolizumab,rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt50,12,19,0,18,12,37,18,31,49,Non-Response,0.00176096386395801,0,0,0.461851892001833,treatment,55,34,21,univariate,0.0875870547177027,1,0.0875870547177027,Pembrolizumab,Anti-PD-1,Pembrolizumab,Anti-PD-1,,TRUE,Anti-PD-1
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75,9,16,0,23,9,39,23,25,48,Non-Response,0.00170541629958605,0,0,0.425467744784737,mechanism,61,34,27,univariate,0.0853891996430769,1,0.0853891996430769,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,,TRUE,Multikinase inhibitor
Lung NSCLC ## Anti-PD-1,neo_ct_lt75,23,21,1,20,24,41,21,44,65,Non-Response,0.000217280488726177,0.0474790532363892,0.00106184371353997,0.348289060859496,mechanism,67,45,22,univariate,0.0252266058092817,0.310770979122748,0.0252266058092817,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,dark,TRUE,Anti-PD-1
Lung NSCLC ## Anti-PD-1,sv_svTmb_chr5_lt50,15,30,0,22,15,52,22,45,67,Non-Response,0.00132932788156587,0,0,0.44008690778707,mechanism,67,45,22,univariate,0.074024370758339,0.911919199651115,0.074024370758339,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,,TRUE,Anti-PD-1
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr11_q_gt75,9,12,0,27,9,39,27,21,48,Non-Response,0.00017526017307999,0,0,0.279960117089177,mechanism,48,21,27,univariate,0.0221161365596688,0.27245256317962,0.0221161365596688,Alkaloid ## Platinum,Alkaloid ## Platinum,Alkaloid ## Platinum,Alkaloid/Platinum,dark,TRUE,Alkaloid/Platinum
Pan-Cancer ## Alkaloid ## Platinum,purity_msIndelsPerMb_gt75,7,14,0,27,7,41,27,21,48,Non-Response,0.00157926749368782,0,0,0.43363464483531,mechanism,48,21,27,univariate,0.081458964257169,1,0.081458964257169,Alkaloid ## Platinum,Alkaloid ## Platinum,Alkaloid ## Platinum,Alkaloid/Platinum,,TRUE,Alkaloid/Platinum
Pan-Cancer ## Nivolumab,rna_geneset_vhio_tcell_lt25,12,54,0,45,12,99,45,66,111,Non-Response,0.0014254707179309,0,0,0.465839978568868,treatment,184,107,77,univariate,0.0773595505201979,0.953005863785769,0.0773595505201979,Nivolumab,Anti-PD-1,Nivolumab,Anti-PD-1,,TRUE,Anti-PD-1
Prostate ## Abiraterone,rna_geneset_KEGG_DORSO_VENTRAL_AXIS_FORMATION_gt25,17,16,0,13,17,29,13,33,46,Non-Response,0.000718022102545829,0,0,0.385418843593935,treatment,57,41,16,univariate,0.0509208477890059,0.627302850204579,0.0509208477890059,Abiraterone,Anti-AR,Abiraterone,Anti-AR,,TRUE,Anti-AR
Prostate ## Abiraterone,rna_geneset_KEGG_HEDGEHOG_SIGNALING_PATHWAY_gt75,16,17,0,13,16,30,13,33,46,Non-Response,0.00151550832533295,0,0,0.434363457252052,treatment,57,41,16,univariate,0.0800996157253949,0.986761207374875,0.0800996157253949,Abiraterone,Anti-AR,Abiraterone,Anti-AR,,TRUE,Anti-AR
Prostate ## Abiraterone,rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,19,14,0,13,19,27,13,33,46,Non-Response,0.000210736978598085,0,0,0.304120372178034,treatment,57,41,16,univariate,0.0248570790009062,0.306218713593285,0.0248570790009062,Abiraterone,Anti-AR,Abiraterone,Anti-AR,dark,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_battle_tgfb_caf_Pdgfra_gt50,18,40,0,21,18,61,21,58,79,Non-Response,0.00206655839482088,0,0,0.495726926608608,mechanism,97,68,29,univariate,0.0974296660847348,1,0.0974296660847348,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_gene_set_tgfb_caf_Pdgfra_gt50,18,40,0,21,18,61,21,58,79,Non-Response,0.00206655839482088,0,0,0.495726926608608,mechanism,97,68,29,univariate,0.0974296660847348,1,0.0974296660847348,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_HALLMARK_WNT_BETA_CATENIN_SIGNALING_gt50,25,33,1,20,26,53,21,58,79,Non-Response,0.000974768057642071,0.0676765866874505,0.00153720083832879,0.480968877321353,mechanism,97,68,29,univariate,0.0600810715842151,0.740149252901102,0.0600810715842151,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_ASTHMA_gt50,19,39,0,21,19,60,21,58,79,Non-Response,0.00194671643287638,0,0,0.456374512285693,mechanism,97,68,29,univariate,0.0938199428275241,1,0.0938199428275241,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25,22,36,0,21,22,57,21,58,79,Non-Response,0.000408807422513273,0,0,0.361316939498367,mechanism,97,68,29,univariate,0.0364041272606048,0.448468825271956,0.0364041272606048,Anti-AR,Anti-AR,Anti-AR,Anti-AR,dark,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_INOSITOL_PHOSPHATE_METABOLISM_gt50,18,40,0,21,18,61,21,58,79,Non-Response,0.00206655839482088,0,0,0.495726926608608,mechanism,97,68,29,univariate,0.0974296660847348,1,0.0974296660847348,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM_gt50,24,34,1,20,25,54,21,58,79,Non-Response,0.00199296233981728,0.0725701419018719,0.00164676605006766,0.516698409500218,mechanism,97,68,29,univariate,0.0953542993470111,1,0.0953542993470111,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt50,18,40,0,21,18,61,21,58,79,Non-Response,0.00206655839482088,0,0,0.495726926608608,mechanism,97,68,29,univariate,0.0974296660847348,1,0.0974296660847348,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Bladder Urothelial ## Anti-PD-1,clin_hasRadiotherapyPreTreatment_and_sv_svTmb_chr3_chr6_eq0,12,25,0,22,12,47,22,37,59,Non-Response,0.00206335286182551,0,0,0.477737911467953,mechanism,59,37,22,combination,0.0974296660847348,1,0.0974296660847348,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,,TRUE,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,purity_tmbPerMb_lt75_and_rna_geneset_HALLMARK_MYC_TARGETS_V1_lt75,15,19,0,19,15,38,19,34,53,Non-Response,0.000347678189854338,0,0,0.339465106491861,mechanism,53,34,19,combination,0.03269735245767,0.402804416686647,0.03269735245767,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,dark,TRUE,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt25_and_rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt50,14,20,0,19,14,39,19,34,53,Non-Response,0.000779316045332524,0,0,0.383747990351625,mechanism,53,34,19,combination,0.0533131887421224,0.65677451777715,0.0533131887421224,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,,TRUE,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt25_and_sv_svTmb_chr3_chr6_eq0,19,15,1,18,20,33,19,34,53,Non-Response,0.000263983556433127,0.0462568202414279,0.00100684588098332,0.357698935478,mechanism,53,34,19,combination,0.0279165386196708,0.343908732952137,0.0279165386196708,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,dark,TRUE,Anti-PD-1
Bladder Urothelial ## Anti-PD-1,rna_geneset_HALLMARK_MYC_TARGETS_V1_lt75_and_sv_svTmb_chr3_chr6_eq0,22,12,1,18,23,30,19,34,53,Non-Response,2.5910930601737e-05,0.0323906031752564,0.00070244849295432,0.252342157216921,mechanism,53,34,19,combination,0.00761212287850749,0.0937750761256219,0.00761212287850749,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,dark,TRUE,Anti-PD-1
Bladder Urothelial ## Pembrolizumab,purity_tmbPerMb_lt75_and_rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt25,12,19,0,18,12,37,18,31,49,Non-Response,0.00176096386395801,0,0,0.461851892001833,treatment,49,31,18,combination,0.0875870547177027,1,0.0875870547177027,Pembrolizumab,Anti-PD-1,Pembrolizumab,Anti-PD-1,,TRUE,Anti-PD-1
Bladder Urothelial ## Pembrolizumab,rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt25_and_rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt50,12,19,0,18,12,37,18,31,49,Non-Response,0.00176096386395801,0,0,0.461851892001833,treatment,49,31,18,combination,0.0875870547177027,1,0.0875870547177027,Pembrolizumab,Anti-PD-1,Pembrolizumab,Anti-PD-1,,TRUE,Anti-PD-1
Bladder Urothelial ## Pembrolizumab,rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt25_and_sv_svTmb_chr3_chr6_eq0,17,14,0,18,17,32,18,31,49,Non-Response,4.29773511314627e-05,0,0,0.239776786653721,treatment,49,31,18,combination,0.0105312340658925,0.129736118555596,0.0105312340658925,Pembrolizumab,Anti-PD-1,Pembrolizumab,Anti-PD-1,dark,TRUE,Anti-PD-1
Bladder Urothelial ## Pembrolizumab,rna_geneset_HALLMARK_HEDGEHOG_SIGNALING_gt50_and_sv_svTmb_chr15_chr17_eq0,12,19,0,18,12,37,18,31,49,Non-Response,0.00176096386395801,0,0,0.461851892001833,treatment,49,31,18,combination,0.0875870547177027,1,0.0875870547177027,Pembrolizumab,Anti-PD-1,Pembrolizumab,Anti-PD-1,,TRUE,Anti-PD-1
Colorectum ## CAPEOX + Bevacizumab,rna_geneset_gene_set_immune_checkpoint_genes_gt75_and_rna_geneset_KEGG_TYPE_II_DIABETES_MELLITUS_gt75,5,8,0,29,5,37,29,13,42,Non-Response,0.00151292866312122,0,0,0.387944616377178,treatment,42,13,29,combination,0.0800996157253949,0.986761207374875,0.0800996157253949,CAPEOX + Bevacizumab,CAPEOX + Bevacizumab,CAPEOX + Bevacizumab,CAPEOX + Bevacizumab,,TRUE,CAPEOX + Bevacizumab
Kidney ## Multikinase inhibitor,rna_geneset_KEGG_HISTIDINE_METABOLISM_lt75_and_rna_geneset_KEGG_LIMONENE_AND_PINENE_DEGRADATION_lt50,12,13,0,23,12,36,23,25,48,Non-Response,9.40507511753335e-05,0,0,0.254580900197091,mechanism,48,25,23,combination,0.0167242827594423,0.20602937103672,0.0167242827594423,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,dark,TRUE,Multikinase inhibitor
Kidney ## Pazopanib,rna_geneset_KEGG_HISTIDINE_METABOLISM_lt75_and_rna_geneset_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY_gt75,10,6,0,16,10,22,16,16,32,Non-Response,0.000248262965291548,0,0,0.247252507443462,treatment,32,16,16,combination,0.0271999392926231,0.335080820224244,0.0271999392926231,Pazopanib,Multikinase inhibitor,Pazopanib,Multikinase inhibitor,dark,TRUE,Multikinase inhibitor
Kidney ## Pazopanib,rna_geneset_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY_gt50_and_rna_geneset_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS_gt50,11,5,0,16,11,21,16,16,32,Non-Response,6.77080814431495e-05,0,0,0.194011591834457,treatment,32,16,16,combination,0.0136962884426889,0.168726978249129,0.0136962884426889,Pazopanib,Multikinase inhibitor,Pazopanib,Multikinase inhibitor,dark,TRUE,Multikinase inhibitor
Kidney ## Pazopanib,rna_geneset_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY_gt75_and_rna_geneset_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS_gt50,9,7,0,16,9,23,16,16,32,Non-Response,0.000815721171672229,0,0,0.314294143309377,treatment,32,16,16,combination,0.0551074928191,0.678878864238263,0.0551074928191,Pazopanib,Multikinase inhibitor,Pazopanib,Multikinase inhibitor,,TRUE,Multikinase inhibitor
Lung NSCLC ## Anti-PD-1,clin_hasSystemicPreTreatment_and_neo_ct_lt75,22,22,1,20,23,42,21,44,65,Non-Response,0.000249437764173415,0.0519010172552296,0.00116023026194187,0.381034109650429,mechanism,65,44,21,combination,0.0271999392926231,0.335080820224244,0.0271999392926231,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,dark,TRUE,Anti-PD-1
Lung NSCLC ## Anti-PD-1,clin_pretreatment_contains_Platinum_and_neo_ct_lt75,22,22,1,20,23,42,21,44,65,Non-Response,0.000249437764173415,0.0519010172552296,0.00116023026194187,0.381034109650429,mechanism,65,44,21,combination,0.0271999392926231,0.335080820224244,0.0271999392926231,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,dark,TRUE,Anti-PD-1
Lung NSCLC ## Anti-PD-1,cn_simple_chr3_p_lt75_and_neo_ct_lt75,22,22,0,21,22,43,21,44,65,Non-Response,3.56826654516781e-05,0,0,0.229357000224767,mechanism,65,44,21,combination,0.00923182507934794,0.113728471467347,0.00923182507934794,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,dark,TRUE,Anti-PD-1
Lung NSCLC ## Anti-PD-1,cn_simple_chr3_p_lt75_and_purity_tmbPerMb_lt75,16,29,0,22,16,51,22,45,67,Non-Response,0.000667702649257513,0,0,0.397123750983228,mechanism,67,45,22,combination,0.0487830306289025,0.600966705855492,0.0487830306289025,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,dark,TRUE,Anti-PD-1
Lung NSCLC ## Anti-PD-1,cn_simple_chr3_p_lt75_and_sv_svTmb_chr5_lt50,15,30,0,22,15,52,22,45,67,Non-Response,0.00132932788156587,0,0,0.44008690778707,mechanism,67,45,22,combination,0.074024370758339,0.911919199651115,0.074024370758339,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,,TRUE,Anti-PD-1
Lung NSCLC ## Anti-PD-1,neo_ct_lt75_and_sv_svTmb_chr1_chr5_eq0,21,23,1,20,22,43,21,44,65,Non-Response,0.000553350309771608,0.0567426515036287,0.00126757423036192,0.417105689299826,mechanism,65,44,21,combination,0.0432963044493232,0.533374764240465,0.0432963044493232,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,dark,TRUE,Anti-PD-1
Lung NSCLC ## Anti-PD-1,neo_ct_lt75_and_sv_svTmb_chr12_chr19_eq0,23,21,1,20,24,41,21,44,65,Non-Response,0.000217280488726177,0.0474790532363892,0.00106184371353997,0.348289060859496,mechanism,65,44,21,combination,0.0252266058092817,0.310770979122748,0.0252266058092817,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,dark,TRUE,Anti-PD-1
Lung NSCLC ## Anti-PD-1,sv_svTmb_chr12_chr19_eq0_and_sv_svTmb_chr5_lt50,15,30,0,22,15,52,22,45,67,Non-Response,0.00132932788156587,0,0,0.44008690778707,mechanism,67,45,22,combination,0.074024370758339,0.911919199651115,0.074024370758339,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,,TRUE,Anti-PD-1
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr10_q_gt25_and_cn_simple_chr11_q_gt75,9,12,0,27,9,39,27,21,48,Non-Response,0.00017526017307999,0,0,0.279960117089177,mechanism,48,21,27,combination,0.0221161365596688,0.27245256317962,0.0221161365596688,Alkaloid ## Platinum,Alkaloid ## Platinum,Alkaloid ## Platinum,Alkaloid/Platinum,dark,TRUE,Alkaloid/Platinum
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr11_q_gt75_and_cn_simple_chr2_q_gt50,8,13,0,27,8,40,27,21,48,Non-Response,0.000539262071015353,0,0,0.345197829624199,mechanism,48,21,27,combination,0.0426719536093949,0.525683276796314,0.0426719536093949,Alkaloid ## Platinum,Alkaloid ## Platinum,Alkaloid ## Platinum,Alkaloid/Platinum,dark,TRUE,Alkaloid/Platinum
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr11_q_gt75_and_cn_simple_chr3_p_gt25,9,12,0,27,9,39,27,21,48,Non-Response,0.00017526017307999,0,0,0.279960117089177,mechanism,48,21,27,combination,0.0221161365596688,0.27245256317962,0.0221161365596688,Alkaloid ## Platinum,Alkaloid ## Platinum,Alkaloid ## Platinum,Alkaloid/Platinum,dark,TRUE,Alkaloid/Platinum
Pan-Cancer ## Alkaloid ## Platinum,cn_simple_chr11_q_gt75_and_cn_simple_chr3_p_gt50,8,13,0,27,8,40,27,21,48,Non-Response,0.000539262071015353,0,0,0.345197829624199,mechanism,48,21,27,combination,0.0426719536093949,0.525683276796314,0.0426719536093949,Alkaloid ## Platinum,Alkaloid ## Platinum,Alkaloid ## Platinum,Alkaloid/Platinum,dark,TRUE,Alkaloid/Platinum
Pan-Cancer ## Anti-EGFR,rna_geneset_HALLMARK_APICAL_SURFACE_lt50_and_rna_geneset_KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM_gt50,26,6,1,16,27,22,17,32,49,Non-Response,3.14017555044041e-07,0.0163287635702596,0.000338801857453216,0.13914620041783,mechanism,49,32,17,combination,0.000331797809547291,0.00408747537910376,0.000331797809547291,Anti-EGFR,Anti-EGFR,Anti-EGFR,Anti-EGFR,dark,TRUE,Anti-EGFR
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_10_lt75_and_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,38,153,2,116,40,269,118,191,309,Non-Response,4.43625360877314e-07,0.0697931670911557,0.0079863812796351,0.279714774090507,mechanism,309,191,118,combination,0.000395606848411289,0.00487355011442744,0.000395606848411289,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,dark,TRUE,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_gene_set_t_cell_gep_6_lt75_and_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,38,153,2,116,40,269,118,191,309,Non-Response,4.43625360877314e-07,0.0697931670911557,0.0079863812796351,0.279714774090507,mechanism,309,191,118,combination,0.000395606848411289,0.00487355011442744,0.000395606848411289,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,dark,TRUE,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_AXON_GUIDANCE_gt75_and_rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75,35,156,1,117,36,273,118,191,309,Non-Response,2.51450134493715e-07,0.0383188411037146,0.000934824092303003,0.235034316283594,mechanism,309,191,118,combination,0.000270229376162143,0.00332900305544632,0.000270229376162143,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,dark,TRUE,Anti-PD-1
Pan-Cancer ## Anti-PD-1,rna_geneset_KEGG_BASAL_CELL_CARCINOMA_gt75_and_rna_geneset_KEGG_RENIN_ANGIOTENSIN_SYSTEM_gt50,29,162,1,117,30,279,118,191,309,Non-Response,5.88627531853135e-06,0.048010529676059,0.00116379818403485,0.298238896773022,mechanism,309,191,118,combination,0.00291389167717124,0.035896742368684,0.00291389167717124,Anti-PD-1,Anti-PD-1,Anti-PD-1,Anti-PD-1,dark,TRUE,Anti-PD-1
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_ACUTE_MYELOID_LEUKEMIA_gt75_and_rna_geneset_KEGG_MELANOMA_gt50,6,9,0,42,6,51,42,15,57,Non-Response,0.000137923424914488,0,0,0.229374670224477,mechanism,57,15,42,combination,0.0204266379292084,0.251639333386274,0.0204266379292084,Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,Anti-VEGF/Platinum/Pyrimidine (ant)agonist,dark,TRUE,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_APOPTOSIS_gt75_and_rna_geneset_KEGG_MELANOMA_gt50,6,9,0,42,6,51,42,15,57,Non-Response,0.000137923424914488,0,0,0.229374670224477,mechanism,57,15,42,combination,0.0204266379292084,0.251639333386274,0.0204266379292084,Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,Anti-VEGF/Platinum/Pyrimidine (ant)agonist,dark,TRUE,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_APOPTOSIS_gt75_and_rna_geneset_KEGG_MTOR_SIGNALING_PATHWAY_gt50,5,10,0,42,5,52,42,15,57,Non-Response,0.000717201809555335,0,0,0.318613166202725,mechanism,57,15,42,combination,0.0509208477890059,0.627302850204579,0.0509208477890059,Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,Anti-VEGF/Platinum/Pyrimidine (ant)agonist,,TRUE,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,rna_geneset_KEGG_MELANOMA_gt50_and_rna_geneset_KEGG_TYPE_II_DIABETES_MELLITUS_gt75,6,9,0,42,6,51,42,15,57,Non-Response,0.000137923424914488,0,0,0.229374670224477,mechanism,57,15,42,combination,0.0204266379292084,0.251639333386274,0.0204266379292084,Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,Anti-VEGF ## Platinum ## Pyrimidine (ant)agonist,Anti-VEGF/Platinum/Pyrimidine (ant)agonist,dark,TRUE,Anti-VEGF/Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Aromatase inhibitor,cn_simple_chr3_q_gt25_and_rna_geneset_HALLMARK_ANDROGEN_RESPONSE_lt50,10,21,0,28,10,49,28,31,59,Non-Response,0.000914798323244152,0,0,0.389701474601022,mechanism,59,31,28,combination,0.0590780234042492,0.727792526540372,0.0590780234042492,Aromatase inhibitor,Aromatase inhibitor,Aromatase inhibitor,Aromatase inhibitor,,TRUE,Aromatase inhibitor
Pan-Cancer ## Capecitabine ## Oxaliplatin,cn_simple_chr11_p_gt25_and_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_lt25,19,24,1,20,20,44,21,43,64,Non-Response,0.00127889093114264,0.0653211478720269,0.00145418914973925,0.48354790164347,treatment,64,43,21,combination,0.0723695715121572,0.891533437655409,0.0723695715121572,Capecitabine ## Oxaliplatin,Platinum ## Pyrimidine (ant)agonist,Capecitabine ## Oxaliplatin,Platinum/Pyrimidine (ant)agonist,,TRUE,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Capecitabine ## Oxaliplatin,cn_simple_chr4_p_gt25_and_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_lt25,19,24,1,20,20,44,21,43,64,Non-Response,0.00127889093114264,0.0653211478720269,0.00145418914973925,0.48354790164347,treatment,64,43,21,combination,0.0723695715121572,0.891533437655409,0.0723695715121572,Capecitabine ## Oxaliplatin,Platinum ## Pyrimidine (ant)agonist,Capecitabine ## Oxaliplatin,Platinum/Pyrimidine (ant)agonist,,TRUE,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Capecitabine ## Oxaliplatin,cn_simple_chr5_q_gt25_and_rna_geneset_KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS_lt25,19,24,1,20,20,44,21,43,64,Non-Response,0.00127889093114264,0.0653211478720269,0.00145418914973925,0.48354790164347,treatment,64,43,21,combination,0.0723695715121572,0.891533437655409,0.0723695715121572,Capecitabine ## Oxaliplatin,Platinum ## Pyrimidine (ant)agonist,Capecitabine ## Oxaliplatin,Platinum/Pyrimidine (ant)agonist,,TRUE,Platinum/Pyrimidine (ant)agonist
Pan-Cancer ## Carboplatin ## Paclitaxel,cn_simple_chr17_p_gt75_and_sv_svTmb_chr6_chr8_gt0,9,19,0,41,9,60,41,28,69,Non-Response,0.000121874838951106,0,0,0.271219857386777,treatment,69,28,41,combination,0.0192778913474204,0.237487722872947,0.0192778913474204,Carboplatin ## Paclitaxel,Platinum ## Taxane,Carboplatin ## Paclitaxel,Platinum/Taxane,dark,TRUE,Platinum/Taxane
Pan-Cancer ## Carboplatin ## Paclitaxel,cn_simple_chr18_p_gt50_and_sv_svTmb_chr6_chr8_gt0,11,17,0,41,11,58,41,28,69,Non-Response,1.17743488478187e-05,0,0,0.194137434976519,treatment,69,28,41,combination,0.00434167139020309,0.0534858109395834,0.00434167139020309,Carboplatin ## Paclitaxel,Platinum ## Taxane,Carboplatin ## Paclitaxel,Platinum/Taxane,dark,TRUE,Platinum/Taxane
Pan-Cancer ## Multikinase inhibitor,clin_age_gt25_and_rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75,14,67,0,49,14,116,49,81,130,Non-Response,0.000980780674647441,0,0,0.440593158766242,mechanism,130,81,49,combination,0.0603333661784833,0.743257314234477,0.0603333661784833,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,,TRUE,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_and_drivers_total_gt50,30,80,1,63,31,143,64,110,174,Non-Response,3.18726651703377e-06,0.0428000064631256,0.00102630263489922,0.272329659305808,mechanism,174,110,64,combination,0.00181664908465932,0.0223796185277649,0.00181664908465932,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,dark,TRUE,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_and_rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75,14,67,0,49,14,116,49,81,130,Non-Response,0.000980780674647441,0,0,0.440593158766242,mechanism,130,81,49,combination,0.0603333661784833,0.743257314234477,0.0603333661784833,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,,TRUE,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,cn_simple_chr17_p_lt75_and_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt25,18,63,0,49,18,112,49,81,130,Non-Response,0.00011778142956312,0,0,0.313969131621636,mechanism,130,81,49,combination,0.0187939103939183,0.231525476666156,0.0187939103939183,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,dark,TRUE,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,rna_geneset_Colostage_one_gt25_and_rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75,16,65,0,49,16,114,49,81,130,Non-Response,0.00047991929165529,0,0,0.368494948808556,mechanism,130,81,49,combination,0.0403369598222947,0.496918079014706,0.0403369598222947,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,dark,TRUE,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,rna_geneset_Colostage_one_gt25_and_rna_geneset_KEGG_PROPANOATE_METABOLISM_lt25,20,61,1,48,21,109,49,81,130,Non-Response,0.0003893359235911,0.0644210898313567,0.00150704590696535,0.431840210463271,mechanism,130,81,49,combination,0.0351012745362836,0.432418754174359,0.0351012745362836,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,dark,TRUE,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,rna_geneset_HALLMARK_TNFA_SIGNALING_VIA_NFKB_gt25_and_rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75,17,64,0,49,17,113,49,81,130,Non-Response,0.000234937044143572,0,0,0.339467998875617,mechanism,130,81,49,combination,0.0268062740984795,0.330231189689108,0.0268062740984795,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,dark,TRUE,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75_and_rna_geneset_KEGG_HUNTINGTONS_DISEASE_lt50,13,68,0,49,13,117,49,81,130,Non-Response,0.0018254152900871,0,0,0.486055199411062,mechanism,130,81,49,combination,0.0900800893818571,1,0.0900800893818571,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,,TRUE,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75_and_rna_geneset_KEGG_OXIDATIVE_PHOSPHORYLATION_lt50,14,67,0,49,14,116,49,81,130,Non-Response,0.000980780674647441,0,0,0.440593158766242,mechanism,130,81,49,combination,0.0603333661784833,0.743257314234477,0.0603333661784833,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,,TRUE,Multikinase inhibitor
Pan-Cancer ## Multikinase inhibitor,rna_geneset_KEGG_ERBB_SIGNALING_PATHWAY_gt75_and_rna_geneset_KEGG_PARKINSONS_DISEASE_lt75,15,66,0,49,15,115,49,81,130,Non-Response,0.00100097868227478,0,0,0.401836795906867,mechanism,130,81,49,combination,0.0612164676808688,0.754136396447754,0.0612164676808688,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,Multikinase inhibitor,,TRUE,Multikinase inhibitor
Pan-Cancer ## Nivolumab,cider_dna_IGH_eq0_and_rna_geneset_CD_8_T_effector_lt50,19,41,1,44,20,85,45,60,105,Non-Response,8.6918348868175e-05,0.0500793534425678,0.00115959406376223,0.343141121695352,treatment,105,60,45,combination,0.0160719696323332,0.197993411275073,0.0160719696323332,Nivolumab,Anti-PD-1,Nivolumab,Anti-PD-1,dark,TRUE,Anti-PD-1
Pan-Cancer ## Nivolumab,cider_dna_IGH_eq0_and_rna_geneset_gene_set_cd8_t_effector_lt50,19,41,1,44,20,85,45,60,105,Non-Response,8.6918348868175e-05,0.0500793534425678,0.00115959406376223,0.343141121695352,treatment,105,60,45,combination,0.0160719696323332,0.197993411275073,0.0160719696323332,Nivolumab,Anti-PD-1,Nivolumab,Anti-PD-1,dark,TRUE,Anti-PD-1
Pan-Cancer ## Nivolumab,cider_dna_IGH_eq0_and_rna_geneset_gene_set_t_cell_gep_10_lt50,19,41,1,44,20,85,45,60,105,Non-Response,8.6918348868175e-05,0.0500793534425678,0.00115959406376223,0.343141121695352,treatment,105,60,45,combination,0.0160719696323332,0.197993411275073,0.0160719696323332,Nivolumab,Anti-PD-1,Nivolumab,Anti-PD-1,dark,TRUE,Anti-PD-1
Pan-Cancer ## Nivolumab,cider_dna_IGH_eq0_and_rna_geneset_gene_set_t_cell_gep_6_lt50,19,41,1,44,20,85,45,60,105,Non-Response,8.6918348868175e-05,0.0500793534425678,0.00115959406376223,0.343141121695352,treatment,105,60,45,combination,0.0160719696323332,0.197993411275073,0.0160719696323332,Nivolumab,Anti-PD-1,Nivolumab,Anti-PD-1,dark,TRUE,Anti-PD-1
Pan-Cancer ## Nivolumab,cn_simple_chr15_q_gt25_and_rna_geneset_CD_8_T_effector_lt50,15,51,0,45,15,96,45,66,111,Non-Response,0.000320950969857723,0,0,0.342563003582781,treatment,111,66,45,combination,0.0312536632534958,0.385019356305473,0.0312536632534958,Nivolumab,Anti-PD-1,Nivolumab,Anti-PD-1,dark,TRUE,Anti-PD-1
Pan-Cancer ## Nivolumab,cn_simple_chr15_q_gt25_and_rna_geneset_gene_set_cd8_t_effector_lt50,15,51,0,45,15,96,45,66,111,Non-Response,0.000320950969857723,0,0,0.342563003582781,treatment,111,66,45,combination,0.0312536632534958,0.385019356305473,0.0312536632534958,Nivolumab,Anti-PD-1,Nivolumab,Anti-PD-1,dark,TRUE,Anti-PD-1
Pan-Cancer ## Nivolumab,cn_simple_chr17_p_gt25_and_rna_geneset_CD_8_T_effector_lt50,19,47,1,44,20,91,45,66,111,Non-Response,0.000249947223875926,0.0572210708254906,0.00132843077799094,0.390333476487109,treatment,111,66,45,combination,0.0271999392926231,0.335080820224244,0.0271999392926231,Nivolumab,Anti-PD-1,Nivolumab,Anti-PD-1,dark,TRUE,Anti-PD-1
Pan-Cancer ## Nivolumab,cn_simple_chr17_p_gt25_and_rna_geneset_gene_set_cd8_t_effector_lt50,19,47,1,44,20,91,45,66,111,Non-Response,0.000249947223875926,0.0572210708254906,0.00132843077799094,0.390333476487109,treatment,111,66,45,combination,0.0271999392926231,0.335080820224244,0.0271999392926231,Nivolumab,Anti-PD-1,Nivolumab,Anti-PD-1,dark,TRUE,Anti-PD-1
Pan-Cancer ## Nivolumab,rna_geneset_CD_8_T_effector_lt50_and_rna_geneset_gene_set_t_cell_gep_10_lt50,25,41,1,44,26,85,45,66,111,Non-Response,5.52608877216742e-06,0.038079288483488,0.000893062439676955,0.254155168652176,treatment,111,66,45,combination,0.00282886499799993,0.0348492838030175,0.00282886499799993,Nivolumab,Anti-PD-1,Nivolumab,Anti-PD-1,dark,TRUE,Anti-PD-1
Pan-Cancer ## Nivolumab,rna_geneset_CD_8_T_effector_lt50_and_rna_geneset_gene_set_t_cell_gep_6_lt50,24,42,1,44,25,86,45,66,111,Non-Response,6.83520889970966e-06,0.040609835485633,0.000951095381708339,0.271727037825162,treatment,111,66,45,combination,0.00318313146900627,0.0392135545613331,0.00318313146900627,Nivolumab,Anti-PD-1,Nivolumab,Anti-PD-1,dark,TRUE,Anti-PD-1
Pan-Cancer ## Nivolumab,rna_geneset_gene_set_cd8_t_effector_lt50_and_rna_geneset_gene_set_t_cell_gep_10_lt50,25,41,1,44,26,85,45,66,111,Non-Response,5.52608877216742e-06,0.038079288483488,0.000893062439676955,0.254155168652176,treatment,111,66,45,combination,0.00282886499799993,0.0348492838030175,0.00282886499799993,Nivolumab,Anti-PD-1,Nivolumab,Anti-PD-1,dark,TRUE,Anti-PD-1
Pan-Cancer ## Nivolumab,rna_geneset_gene_set_cd8_t_effector_lt50_and_rna_geneset_gene_set_t_cell_gep_6_lt50,24,42,1,44,25,86,45,66,111,Non-Response,6.83520889970966e-06,0.040609835485633,0.000951095381708339,0.271727037825162,treatment,111,66,45,combination,0.00318313146900627,0.0392135545613331,0.00318313146900627,Nivolumab,Anti-PD-1,Nivolumab,Anti-PD-1,dark,TRUE,Anti-PD-1
Pan-Cancer ## Nivolumab,rna_geneset_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION_lt75_and_rna_geneset_KEGG_AXON_GUIDANCE_gt75,13,53,0,45,13,98,45,66,111,Non-Response,0.00074652569673796,0,0,0.417603454366183,treatment,111,66,45,combination,0.0518313904232124,0.638519984531117,0.0518313904232124,Nivolumab,Anti-PD-1,Nivolumab,Anti-PD-1,,TRUE,Anti-PD-1
Pan-Cancer ## Pazopanib,rna_geneset_KEGG_ARGININE_AND_PROLINE_METABOLISM_lt50_and_rna_geneset_KEGG_HISTIDINE_METABOLISM_lt75,19,10,1,18,20,28,19,29,48,Non-Response,2.47514594337295e-05,0.0316172829128716,0.000673763232471629,0.254420043531213,treatment,48,29,19,combination,0.0073923966894971,0.0910682306857749,0.0073923966894971,Pazopanib,Multikinase inhibitor,Pazopanib,Multikinase inhibitor,dark,TRUE,Multikinase inhibitor
Pan-Cancer ## Pazopanib,rna_geneset_KEGG_BETA_ALANINE_METABOLISM_lt75_and_rna_geneset_KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION_lt75,19,10,1,18,20,28,19,29,48,Non-Response,2.47514594337295e-05,0.0316172829128716,0.000673763232471629,0.254420043531213,treatment,48,29,19,combination,0.0073923966894971,0.0910682306857749,0.0073923966894971,Pazopanib,Multikinase inhibitor,Pazopanib,Multikinase inhibitor,dark,TRUE,Multikinase inhibitor
Pan-Cancer ## Pembrolizumab,purity_tmbPerMb_lt75_and_rna_geneset_HALLMARK_COAGULATION_gt50,29,96,0,73,29,169,73,125,198,Non-Response,4.66479790756219e-07,0,0,0.187467089706464,treatment,198,125,73,combination,0.00041016948202871,0.00505294975075214,0.00041016948202871,Pembrolizumab,Anti-PD-1,Pembrolizumab,Anti-PD-1,dark,TRUE,Anti-PD-1
Pan-Cancer ## Pembrolizumab,rna_geneset_gene_set_t_cell_gep_6_lt75_and_rna_geneset_HALLMARK_COAGULATION_gt50,43,82,2,71,45,153,73,125,198,Non-Response,3.72968594807561e-08,0.0542820347469463,0.00616151746361182,0.221275397795327,treatment,198,125,73,combination,6.79656886578451e-05,0.00083728123278396,6.79656886578451e-05,Pembrolizumab,Anti-PD-1,Pembrolizumab,Anti-PD-1,dark,TRUE,Anti-PD-1
Pan-Cancer ## Platinum ## Taxane,cn_simple_chr7_p_gt75_and_rna_geneset_KEGG_DRUG_METABOLISM_OTHER_ENZYMES_gt50,8,20,0,34,8,54,34,28,62,Non-Response,0.000919258920919739,0,0,0.397380034624888,mechanism,62,28,34,combination,0.0592443763191215,0.729841857259917,0.0592443763191215,Platinum ## Taxane,Platinum ## Taxane,Platinum ## Taxane,Platinum/Taxane,,TRUE,Platinum/Taxane
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr13_q_gt25_and_sv_svTmb_chr5_chr6_gt0,14,59,0,40,14,99,40,73,113,Non-Response,0.00192935909373831,0,0,0.480802929089065,mechanism,113,73,40,combination,0.0933771184482169,1,0.0933771184482169,Pyrimidine (ant)agonist,Pyrimidine (ant)agonist,Pyrimidine (ant)agonist,Pyrimidine (ant)agonist,,TRUE,Pyrimidine (ant)agonist
Pan-Cancer ## Pyrimidine (ant)agonist,cn_simple_chr22_q_gt50_and_rna_geneset_KEGG_RIBOSOME_gt50,24,40,1,32,25,72,33,64,97,Non-Response,0.000143641208808687,0.0532097663548201,0.00123377416500823,0.36267481153457,mechanism,97,64,33,combination,0.0205332966843472,0.252953281287831,0.0205332966843472,Pyrimidine (ant)agonist,Pyrimidine (ant)agonist,Pyrimidine (ant)agonist,Pyrimidine (ant)agonist,dark,TRUE,Pyrimidine (ant)agonist
Prostate ## Abiraterone,drivers_pathway_DDR_gt0_and_rna_geneset_HALLMARK_OXIDATIVE_PHOSPHORYLATION_lt75,16,17,0,13,16,30,13,33,46,Non-Response,0.00151550832533295,0,0,0.434363457252052,treatment,46,33,13,combination,0.0800996157253949,0.986761207374875,0.0800996157253949,Abiraterone,Anti-AR,Abiraterone,Anti-AR,,TRUE,Anti-AR
Prostate ## Abiraterone,drivers_pathway_DDR_gt0_and_sv_svTmb_chr2_gt50,22,19,0,16,22,35,16,41,57,Non-Response,0.000129733403554603,0,0,0.270111218098343,treatment,57,41,16,combination,0.0200247326951581,0.246688192355069,0.0200247326951581,Abiraterone,Anti-AR,Abiraterone,Anti-AR,dark,TRUE,Anti-AR
Prostate ## Abiraterone,rna_geneset_HALLMARK_OXIDATIVE_PHOSPHORYLATION_lt75_and_rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,18,15,0,13,18,28,13,33,46,Non-Response,0.000491322038871397,0,0,0.342316236374235,treatment,46,33,13,combination,0.0408854073617549,0.50367450039474,0.0408854073617549,Abiraterone,Anti-AR,Abiraterone,Anti-AR,dark,TRUE,Anti-AR
Prostate ## Abiraterone,rna_geneset_KEGG_DORSO_VENTRAL_AXIS_FORMATION_gt25_and_rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,16,17,0,13,16,30,13,33,46,Non-Response,0.00151550832533295,0,0,0.434363457252052,treatment,46,33,13,combination,0.0800996157253949,0.986761207374875,0.0800996157253949,Abiraterone,Anti-AR,Abiraterone,Anti-AR,,TRUE,Anti-AR
Prostate ## Abiraterone,rna_geneset_KEGG_PARKINSONS_DISEASE_lt75_and_rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,17,16,0,13,17,29,13,33,46,Non-Response,0.000718022102545829,0,0,0.385418843593935,treatment,46,33,13,combination,0.0509208477890059,0.627302850204579,0.0509208477890059,Abiraterone,Anti-AR,Abiraterone,Anti-AR,,TRUE,Anti-AR
Prostate ## Abiraterone,rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25_and_sv_svTmb_chr2_gt50,17,16,0,13,17,29,13,33,46,Non-Response,0.000718022102545829,0,0,0.385418843593935,treatment,46,33,13,combination,0.0509208477890059,0.627302850204579,0.0509208477890059,Abiraterone,Anti-AR,Abiraterone,Anti-AR,,TRUE,Anti-AR
Prostate ## Abiraterone,rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25_and_sv_svTmb_chr22_gt50,16,17,0,13,16,30,13,33,46,Non-Response,0.00151550832533295,0,0,0.434363457252052,treatment,46,33,13,combination,0.0800996157253949,0.986761207374875,0.0800996157253949,Abiraterone,Anti-AR,Abiraterone,Anti-AR,,TRUE,Anti-AR
Prostate ## Abiraterone,sv_svTmb_chr22_gt50_and_sv_svTmb_chr7_gt75,17,24,0,16,17,40,16,41,57,Non-Response,0.00123631189453416,0,0,0.440713129987527,treatment,57,41,16,combination,0.0705955426861654,0.86967886556539,0.0705955426861654,Abiraterone,Anti-AR,Abiraterone,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,chord_BRCA1_eq0_and_rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25,18,40,0,21,18,61,21,58,79,Non-Response,0.00206655839482088,0,0,0.495726926608608,mechanism,79,58,21,combination,0.0974296660847348,1,0.0974296660847348,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,cn_simple_chr12_p_lt75_and_rna_geneset_HALLMARK_WNT_BETA_CATENIN_SIGNALING_gt50,24,34,1,20,25,54,21,58,79,Non-Response,0.00199296233981728,0.0725701419018719,0.00164676605006766,0.516698409500218,mechanism,79,58,21,combination,0.0953542993470111,1,0.0953542993470111,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,cn_simple_chr12_p_lt75_and_rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25,19,39,0,21,19,60,21,58,79,Non-Response,0.00194671643287638,0,0,0.456374512285693,mechanism,79,58,21,combination,0.0938199428275241,1,0.0938199428275241,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,cn_simple_chr12_p_lt75_and_rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,26,32,1,20,27,52,21,58,79,Non-Response,0.000895039635058118,0.0631582768149133,0.00143575847496215,0.448188581720518,mechanism,79,58,21,combination,0.0580404815022886,0.71501086597173,0.0580404815022886,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_HALLMARK_OXIDATIVE_PHOSPHORYLATION_lt75_and_rna_geneset_HALLMARK_WNT_BETA_CATENIN_SIGNALING_gt50,24,34,0,21,24,55,21,58,79,Non-Response,0.000171866665395001,0,0,0.312045398201056,mechanism,79,58,21,combination,0.0221161365596688,0.27245256317962,0.0221161365596688,Anti-AR,Anti-AR,Anti-AR,Anti-AR,dark,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_HALLMARK_OXIDATIVE_PHOSPHORYLATION_lt75_and_rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25,20,38,0,21,20,59,21,58,79,Non-Response,0.000934119516375093,0,0,0.421279159008298,mechanism,79,58,21,combination,0.0595320420177759,0.733385661428687,0.0595320420177759,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_HALLMARK_OXIDATIVE_PHOSPHORYLATION_lt75_and_rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,25,33,1,20,26,53,21,58,79,Non-Response,0.000974768057642071,0.0676765866874505,0.00153720083832879,0.480968877321353,mechanism,79,58,21,combination,0.0600810715842151,0.740149252901102,0.0600810715842151,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_HALLMARK_WNT_BETA_CATENIN_SIGNALING_gt50_and_rna_geneset_KEGG_PARKINSONS_DISEASE_lt75,23,35,0,21,23,56,21,58,79,Non-Response,0.000208496996361692,0,0,0.335537593568647,mechanism,79,58,21,combination,0.0248570790009062,0.306218713593285,0.0248570790009062,Anti-AR,Anti-AR,Anti-AR,Anti-AR,dark,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_HALLMARK_WNT_BETA_CATENIN_SIGNALING_gt50_and_rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,21,37,0,21,21,58,21,58,79,Non-Response,0.000926243913622342,0,0,0.389783301369931,mechanism,79,58,21,combination,0.0594753603489165,0.732687390013858,0.0594753603489165,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_HALLMARK_WNT_BETA_CATENIN_SIGNALING_gt50_and_sv_svTmb_chr11_gt50,19,39,0,21,19,60,21,58,79,Non-Response,0.00194671643287638,0,0,0.456374512285693,mechanism,79,58,21,combination,0.0938199428275241,1,0.0938199428275241,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_HALLMARK_WNT_BETA_CATENIN_SIGNALING_gt50_and_sv_svTmb_chr2_gt50,20,38,0,21,20,59,21,58,79,Non-Response,0.000934119516375093,0,0,0.421279159008298,mechanism,79,58,21,combination,0.0595320420177759,0.733385661428687,0.0595320420177759,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_HALLMARK_WNT_BETA_CATENIN_SIGNALING_gt50_and_sv_svTmb_chr22_gt50,21,37,0,21,21,58,21,58,79,Non-Response,0.000926243913622342,0,0,0.389783301369931,mechanism,79,58,21,combination,0.0594753603489165,0.732687390013858,0.0594753603489165,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25_and_rna_geneset_KEGG_PARKINSONS_DISEASE_lt75,20,38,0,21,20,59,21,58,79,Non-Response,0.000934119516375093,0,0,0.421279159008298,mechanism,79,58,21,combination,0.0595320420177759,0.733385661428687,0.0595320420177759,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25_and_rna_geneset_KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM_gt50,19,39,0,21,19,60,21,58,79,Non-Response,0.00194671643287638,0,0,0.456374512285693,mechanism,79,58,21,combination,0.0938199428275241,1,0.0938199428275241,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25_and_rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,18,40,0,21,18,61,21,58,79,Non-Response,0.00206655839482088,0,0,0.495726926608608,mechanism,79,58,21,combination,0.0974296660847348,1,0.0974296660847348,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES_gt25_and_signature_log_SBS1_gt25,20,38,0,21,20,59,21,58,79,Non-Response,0.000934119516375093,0,0,0.421279159008298,mechanism,79,58,21,combination,0.0595320420177759,0.733385661428687,0.0595320420177759,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM_gt50_and_rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25,20,38,0,21,20,59,21,58,79,Non-Response,0.000934119516375093,0,0,0.421279159008298,mechanism,79,58,21,combination,0.0595320420177759,0.733385661428687,0.0595320420177759,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM_gt50_and_sv_svTmb_chr11_gt50,18,40,0,21,18,61,21,58,79,Non-Response,0.00206655839482088,0,0,0.495726926608608,mechanism,79,58,21,combination,0.0974296660847348,1,0.0974296660847348,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM_gt50_and_sv_svTmb_chr2_gt50,20,38,0,21,20,59,21,58,79,Non-Response,0.000934119516375093,0,0,0.421279159008298,mechanism,79,58,21,combination,0.0595320420177759,0.733385661428687,0.0595320420177759,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM_gt50_and_sv_svTmb_chr22_gt50,19,39,0,21,19,60,21,58,79,Non-Response,0.00194671643287638,0,0,0.456374512285693,mechanism,79,58,21,combination,0.0938199428275241,1,0.0938199428275241,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Anti-AR,rna_geneset_KEGG_TGF_BETA_SIGNALING_PATHWAY_gt25_and_sv_svTmb_chr11_gt50,20,38,0,21,20,59,21,58,79,Non-Response,0.000934119516375093,0,0,0.421279159008298,mechanism,79,58,21,combination,0.0595320420177759,0.733385661428687,0.0595320420177759,Anti-AR,Anti-AR,Anti-AR,Anti-AR,,TRUE,Anti-AR
Prostate ## Taxane,rna_geneset_KEGG_PENTOSE_PHOSPHATE_PATHWAY_gt50_and_sv_svTmb_chr9_chr19_eq0,21,20,1,17,22,37,18,41,59,Non-Response,0.000937282226579891,0.0583206013164177,0.00128617305998703,0.43996382380291,mechanism,59,41,18,combination,0.0597021239137297,0.735480930119854,0.0597021239137297,Taxane,Taxane,Taxane,Taxane,,TRUE,Taxane
